Conference Links:

Agenda

LS 2009 Presenter Application

LS 2009 ExhibitorApplication

Registration

Sponsorship Info 

Speakers Bio

Directions to CCHMS

Parking

Who should attend?

This conference will benefit venture capitalists and angel investors who are interested in early-stage life sciences companies. Key attendees will be business development and senior executives from biotech, pharmaceutical and biomedical companies.

Why attend?

Be among the first to see a range of new companies spun off from Massachusetts research institutions, and see new technologies that are available for commercialization through licensing agreements and the creation of new companies.

Can I present my company/technology at the conference?

MTTC will be glad to consider you as a presenter. To see detailed eligibility criteria and to apply please download the LS 2009 Presenter Application.

Can I exhibit my company/technology at the conference?

MTTC will be glad to consider you as a presenter. To see detailed eligibility criteria and to apply please download the LS 2009 ExhibitorApplication

TECHNOLOGY SHOWCASE FORUM 

Early-Stage Life Sciences Technology Conference V:

March 30, 2009, 1:00-7:00 pm
The Conference Center at Harvard Medical School
77 Avenue Louis Pasteur, Boston , MA

The 5th Early-Stage Life Sciences Technology Conference is an opportunity for research institutions and recently formed Massachusetts companies to present their life sciences technologies to an audience of angel investors, venture capitalists and corporate investors.

Agenda:

1:00 PM - 1:30 PM Registration and Dessert Bar
1:30 PM - 2:30 PM Welcome and Early Stage Funding Panel
2:30 PM - 3:20 PM Company presentations - Session One
3:20 PM - 3:35 PM Coffee Break
3:35 PM - 5:15 PM Company presentations - Session Two
5:15 PM - 7:00 PM Networking Reception and Poster Session

Early Stage Funding Panel

There still is funding for early stage life sciences start-ups, but entrepreneurs have to be patient, persistent and creative in order to obtain it. This panel will include people who have money and are actively funding very early stage life sciences companies as well as entrepreneurs who have recently raised new investments.

Panelists include:
- Carl M. Berke, Associate Director, Partners Innovation Fund and Co-founder, MA Medical Angels
- David Beylin, Program Manager, SBIR Development Center, National Cancer Institute
- Aaron Sandoski, Managing Director, Norwich Ventures
- David Steinmiller, Founder and Chief Operating Officer, Claros Daignostics
Moderator: Robert Buderi, Founder and Editor in Chief, Xconomy

Pitch Presenters include:

  • Acetylon Pharmaceuticals, Inc. (Dana Farber/Harvard University)  
  • Augmentrix (University of Vermont)  
  • Boston College  
  • Cadrus Therapeutics, Inc. (UMass Medical School)  
  • gRadiant Research LLC  
  • Immuneering Corporation (MIT/Harvard University)
  • Lumos Catheter Systems, Inc. (Children's Hospital Boston)
  • Moma Therapeutics, Inc.
  • Orbital Therapy, LLC
  • Robopsy (MGH / MIT)
  • UMass Medical School

Registration:

  • MATTO members, academics/staff at MATTO member institutions, MBC members, and Presenters - $90.00
  • Non-member - $130.00

Click here to Register


Sponsorship Information:

$3,000 Sponsorships Available

Sponsorship benefits:

  • Three complementary conference registrations
  • Recognition in pre-event advertising
  • Designation as sponsor in event signage
  • Opportunity to display sponsor literature on literature table
  • Name and/or logo on printed conference materials and Web site
  • One-page service description and contact information in conference book
  • Acknowledgment and thanks at beginning of meeting
  • Early notification of sponsorship opportunities for future events

For sponsorship information, please contact:

Abigail Barrow
(617) 287-7071
abarrow@umassp.edu


 

 

 

 

 











Produced by

MattCenter Logo

in association with

MBC logo

 

Sponsored by

Merck

Nutter

 

Media Sponsors

 Xconomy